BMS - Autoimmune Disease Drugs Business Funding

BMS - Autoimmune Disease Drugs Business funding overview

BMS - Autoimmune Disease Drugs Business is based in New York City. BMS - Autoimmune Disease Drugs Business has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in July 2025. The round record for BMS - Autoimmune Disease Drugs Business runs through 2025; nothing later has been disclosed. Investors on record include Bain Capital, Bain Capital Life Sciences. 2 distinct backers are named across the disclosed rounds.

BMS - Autoimmune Disease Drugs Business at a glance

Total raised

$300M

Latest round

Series A

Latest round date

July 2025

Headquarters

New York City

Notable investors

Bain Capital, Bain Capital Life Sciences

Frequently asked about BMS - Autoimmune Disease Drugs Business funding

How much has BMS - Autoimmune Disease Drugs Business raised?

BMS - Autoimmune Disease Drugs Business has raised $300M in total disclosed funding across the rounds on record.

Who has invested in BMS - Autoimmune Disease Drugs Business?

Bain Capital, Bain Capital Life Sciences are named among the investors backing BMS - Autoimmune Disease Drugs Business.

What was the latest BMS - Autoimmune Disease Drugs Business funding round?

The most recent disclosed round is a Series A, announced in July 2025.

Where is BMS - Autoimmune Disease Drugs Business based?

BMS - Autoimmune Disease Drugs Business is based in New York City.

When did BMS - Autoimmune Disease Drugs Business last raise?

The last disclosed BMS - Autoimmune Disease Drugs Business round closed in July 2025 at Series A.

Round data for BMS - Autoimmune Disease Drugs Business is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.

Companies related to BMS - Autoimmune Disease Drugs Business (36)

• Envestnet
• SolarWinds
• Crusoe Energy Systems
• Bridge Data Centres
• Acrisure
• Mirakl
• CI U.S. Wealth Management
• Service Logic
• Berlin Brands Group
• Virgin Voyages
• MASAN Group
• Beeline Medicines
• Roofstock
• QuVa Pharma
• Areteia Therapeutics
• Aidacare
• Avistone Pharmaceuticals
• Frontline Road Safety
• The We Company
• Metsera
• Rockefeller Capital Management
• EliseAI
• Polymarket
• Articulate
• MidOcean Partners
• Oscar Health
• Empire State Realty Trust
• Attentive
• Dreamscape
• Cockroach Labs
• Willow Wealth
• Melio
• Duetti
• OnDeck
• ROKT
• Modal Labs

Browse related funding lists (5)

• Series A stage companies
• Companies that raised 100m 500m
• Companies funded in 2025
• Companies backed by Bain Capital
• Companies backed by Bain Capital Life Sciences

Company funding database · Investor directory · Founder database · Mega-rounds 2026